Femme et Homme
- | Pays :
- Finland
- | Organes : -
- | Spécialités : -
Extrait
Primary objective: To check if RotaTeq® can be administered concomitantly with meningococcal Group C vaccine without impairing the efficacy of MCC vaccine. Secondary objectives: - Efficacy: Additional immunogenicity assessments. - Safety: To describe the safety profile of RotaTeq® and of the MCC vaccine when administered concomitantly with RotaTeq®.
Critère d'inclusion
- Meningitis, Meningococcal ,Rotavirus Infections